121124-98-9 Usage
Uses
Used in Organic Synthesis:
4-Benzyloxy-3-formylphenylboronic acid is used as a reagent for the preparation of functionalized aromatic compounds. Its boronic acid functionality allows for the formation of carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions, making it a versatile tool in the field of organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-Benzyloxy-3-formylphenylboronic acid is used as a building block for the synthesis of bioactive molecules. Its formyl group and benzyl ether moiety provide opportunities for further derivatization and functionalization, enabling the development of novel drug candidates with potential therapeutic applications.
Used in Material Science:
4-Benzyloxy-3-formylphenylboronic acid can also be used in material science for the synthesis of advanced materials with specific properties. Its reactivity and functional groups can be exploited to create new polymers, coatings, or other materials with tailored characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 121124-98-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,1,2 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 121124-98:
(8*1)+(7*2)+(6*1)+(5*1)+(4*2)+(3*4)+(2*9)+(1*8)=79
79 % 10 = 9
So 121124-98-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H13BO4/c16-9-12-8-13(15(17)18)6-7-14(12)19-10-11-4-2-1-3-5-11/h1-9,17-18H,10H2
121124-98-9Relevant academic research and scientific papers
Scalable synthesis of the desoxy-biphenomycin B core
Berwe, Mathias,Joentgen, Winfried,Krueger, Jochen,Cancho-Grande, Yolanda,Lampe, Thomas,Michels, Martin,Paulsen, Holger,Raddatz, Siegfried,Weigand, Stefan
, p. 1348 - 1357 (2012/01/12)
We describe the evolution of a kilogram-scale synthesis of the protected cyclic tripeptide desoxy-biphenomycin B, based on an early discovery route. The retrosynthetic concept included a macrolactamization strategy to build the core ring system of biphenomycin B in combination with a double catalytic asymmetric hydrogenation protocol for the construction of the ansa-tripeptide precursor. Eventually, the kilogram process comprised a 16-step sequence with an overall yield for the longest linear sequence of 19.5%.
